Current Challenges and Updates in the Management of Cytomegalovirus in Solid Organ Transplant Recipients

Speaker:
Margaret R. Jorgenson, PharmD
Clinical Pharmacist
UW Health

A Knowledge-Based Activity
ACPE UAN# 0016-9999-21-044-L01-P
0.75 contact hours (0.075 CEUs)
0.75 contact hour CNE

Learning Objectives:

• Describe the epidemiology, treatment, and outcomes of Cytomegalovirus (CMV) infection in solid organ transplant recipients
• Identify key patient specific factors associated with CMV disease, and key toxicities associated with currently available CMV therapies
• Explain how healthcare professionals can use risk factor screening and cell mediated immunity assays to predict outcomes and direct therapy to improve the provision of care in the prophylaxis and treatment of CMV in solid organ transplant recipients

Disclosures:

Dr. Muran is a consultant for Veloxis.  Dr. Shields is co-investigator on a study funded by Bristol Myers Squibb.  All of the other speakers, planning committee members, and reviewers who contributed to this activity have no relevant financial relationships with ineligible companies to disclose.